NSE: MASTEK | BSE: 523704

Mid-range Performer

Download real time

2162.50 -38.80 (-1.76%)

35.93% Fall from 52W High

25,830 NSE+BSE Volume

NSE 28 Oct, 2025 10:54 AM (IST)

6,699.6

Market Cap

High in industry

1.4

Beta 1Year

Very High Volatility

Mastek Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for MASTEK, BSE:523704 Mastek Ltd.

Search Inside the pdf :

Mastek Ltd.

20 Oct 2025

2162.50

-1.76%

About the stock: Mastek Ltd (Mastek) offers data, apps, cloud services to public Geographic strength and strategic focus areas: UK remains Mastek's growth anchor, up 4% QoQ and contributing 65% of revenue, driven by strong demand in Healthcare and Government segments. The company is also restructuring its North America leadership to drive Healthcare growth and emphasis remains on profitability improvement and tighter DSO management.in the Middle East. Continued focus on geo-diversification, AI-led delivery, and mid-market leadership provides visibility for steady, profitable growth through FY2627...

Mastek Ltd. has an average target of 3055.50 from 4 brokers.

Mastek Ltd.

22 Jul 2025

2162.50

-1.76%

MASTEK LTD

Buy: Mastek Ltd.

Geojit BNP Paribas

Mastek Ltd is a Mumbai-based global provider of digital engineering and cloud transformation services, operating in over 40 countries. It partners with Oracle, Salesforce, Microsoft, AWS, and Snowflake to deliver consulting, data analytics, and enterprise solutions. The UK and Europe contribute 64% of revenue, followed by the US and Middle East. Sector-wise, Government and Education lead with 39%,...

Mastek Ltd. is trading below all available SMAs

Mastek Ltd.

22 Jul 2025

2162.50

-1.76%

Mastek: Resilient UK, as NA & AMEA drag. Is this the inflection point? Retaining a Buy

Buy: Mastek Ltd.

Target

Anand Rathi

Mastek’s Q1FY26 performance highlights ongoing execution challenges in NA and AMEA, with CC revenue declining -1.1% q/q, reflecting transition issues coupled with Payer and Retail-client-specific concerns in the US.

Mastek Ltd. has an average target of 3055.50 from 4 brokers.

Mastek Ltd.

21 Apr 2025

2162.50

-1.76%

Mixed Quarter, UK to drive growth

Buy: Mastek Ltd.

Sharekhan

Reported revenues stood at $104.6 million, up 2.9% q-o-q in constant currency (CC) terms, beating our estimates of 1.8% q-o-q growth in CC driven by core business in UK and Europe.

ICICI Direct decreased Buy price target of Mastek Ltd. to 2600.0 on 20 Oct, 2025.

Mastek Ltd.

21 Mar 2025

2162.50

-1.76%

Growth momentum to continue amid merger challenges

Buy: Mastek Ltd.

Sharekhan

We participated in a conference call organised by Mastek’s management to address the concerns stemming from the abolishment of NHS England on account of its merger with the Department of Health and Social Care (DHSC).

Mastek Ltd. has an average target of 3055.50 from 4 brokers.

Mastek Ltd.

27 Feb 2025, 12:00AM

2162.50

-1.76%

UK business on strong footing

Buy: Mastek Ltd.

Target

Sharekhan

Mastek has secured ~$85 million in multiple contracts from a UK public service department to boost Digital, Data and Technology services spread over two years. The company had earlier won a $40 million government services deal during the quarter.

ICICI Direct decreased Buy price target of Mastek Ltd. to 2600.0 on 20 Oct, 2025.

Mastek Ltd.

17 Jan 2025

2162.50

-1.76%

Mixed Quarter, outlook positive

Buy: Mastek Ltd.

Sharekhan

Mastek reported revenues of $102.9 million, up 0.1% q-o-q/7.6% y-o-y in constant currency (CC), missing our estimates of $104.8 million. Revenue in $ terms was down 0.7%q-o-q/up 9.4% y-o-y while revenue in rupee terms stood at Rs 869.5 crore, up 0.2% q-o-q/10.9% y-o-y.

Mastek Ltd. is trading below all available SMAs

Mastek Ltd.

18 Oct 2024

2162.50

-1.76%

Solid Q2; Maintain Buy

Buy: Mastek Ltd.

Target

Sharekhan

Reported revenues stood at $103.6 million, up 4.7% q-o-q/10.2% y-o-y in constant currency (CC) terms, beating our estimates of $101.5 million.

Mastek Ltd. is trading below all available SMAs

Mastek Ltd.

19 Jul 2024

2162.50

-1.76%

Decent Q1; Maintain Buy

Buy: Mastek Ltd.

Sharekhan

Mastek reported revenues of $97.3 million, up 4.1% q-o-q/9.9% y-o-y in constant currency terms, beating our estimates of $95 million.

Mastek Ltd. has an average target of 3055.50 from 4 brokers.

Mastek Ltd.

29 Apr 2024

2162.50

-1.76%

Muted Quarter; Confident commentary

Buy: Mastek Ltd.

Target

Sharekhan

Mastek’s reported revenue stood at $93.7 million, down 1.4% q-o-q/up 6% y-o-y in constant currency (CC) terms, which was lower than our estimate of $96.3 million on account of three specific client situations.

Mastek Ltd. has an average target of 3055.50 from 4 brokers.

Is Mastek Ltd. worth buying?

212 Votes:

Buy 75.47%

Sell 16.98%

Hold 7.55%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf